Programmable Organometallics for Spatiotemporal Light Control. This Project aims to develop new materials that control and modify light. The new organometallics from this Project are anticipated to display world record light intensity-dependent absorption and other phenomena. These new programmable molecules are expected to respond to environmental stimuli with precise spatial control. Anticipated outcomes of this Project include environmental sensors and a technology platform for targeted medic ....Programmable Organometallics for Spatiotemporal Light Control. This Project aims to develop new materials that control and modify light. The new organometallics from this Project are anticipated to display world record light intensity-dependent absorption and other phenomena. These new programmable molecules are expected to respond to environmental stimuli with precise spatial control. Anticipated outcomes of this Project include environmental sensors and a technology platform for targeted medical imaging and light-responsive therapies. This Project should provide significant benefits including possible commercialisation of the new materials, enhanced research capacity, training students and a postdoctoral fellow with unique skills, and the strengthening of research linkages with strategic partners.Read moreRead less
Industrial Transformation Research Hubs - Grant ID: IH220100017
Funder
Australian Research Council
Funding Amount
$4,808,669.00
Summary
ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals. Radiopharmaceuticals are emerging as next generation medical technologies for addressing complex health challenges, and their manufacture offers significant economic benefit to Australia. The ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR) aims to establish a manufacturing platform for new medical technologies combining innovations in biotechnology and pharmaceutical science. The progra ....ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals. Radiopharmaceuticals are emerging as next generation medical technologies for addressing complex health challenges, and their manufacture offers significant economic benefit to Australia. The ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR) aims to establish a manufacturing platform for new medical technologies combining innovations in biotechnology and pharmaceutical science. The program addresses industry-led challenges for translation of biologics as molecular radiopharmaceuticals, building capacity in biomanufacturing, radiobiology and radiochemistry. The program establishes a dedicated manufacturing pipeline, future-proofing production and securing supply chain of next generation medical technologies.Read moreRead less